Robeco Institutional Asset Management B.V. Trims Stock Position in CME Group Inc. (NASDAQ:CME)

Robeco Institutional Asset Management B.V. cut its position in shares of CME Group Inc. (NASDAQ:CME – Get Rating) by 7.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 88,581 shares of the financial services provider’s stock after selling 7,302 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in CME Group were worth $15,691,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Envestnet Asset Management Inc. increased its position in shares of CME Group by 4.6% during the third quarter. Envestnet Asset Management Inc. now owns 360,268 shares of the financial services provider’s stock valued at $63,814,000 after acquiring an additional 15,818 shares during the last quarter. Greenleaf Trust increased its position in shares of CME Group by 2.2% during the third quarter. Greenleaf Trust now owns 4,805 shares of the financial services provider’s stock valued at $851,000 after acquiring an additional 102 shares during the last quarter. Victory Capital Management Inc. increased its position in shares of CME Group by 13.4% during the third quarter. Victory Capital Management Inc. now owns 334,175 shares of the financial services provider’s stock valued at $59,192,000 after acquiring an additional 39,500 shares during the last quarter. Meiji Yasuda Life Insurance Co increased its position in shares of CME Group by 4.7% during the second quarter. Meiji Yasuda Life Insurance Co now owns 6,699 shares of the financial services provider’s stock valued at $1,371,000 after acquiring an additional 298 shares during the last quarter. Finally, Keebeck Alpha LP grew its holdings in shares of CME Group by 28.2% in the third quarter. Keebeck Alpha LP now owns 2,050 shares of the financial services provider’s stock valued at $363,000 after purchasing an additional 451 shares in the last quarter. 85.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Credit Suisse Group lifted their price objective on shares of CME Group from $192.00 to $198.00 and gave the company an “outperform” rating in a report on Tuesday, February 7th. StockNews.com assumed coverage on shares of CME Group in a report on Thursday. They issued a “hold” rating for the company. Oppenheimer dropped their price objective on shares of CME Group from $218.00 to $213.00 and set an “outperform” rating for the company in a report on Thursday, January 19th. Rosenblatt Securities restated a “sell” rating and issued a $161.00 price objective on shares of CME Group in a report on Thursday, February 9th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of CME Group from $200.00 to $218.00 in a report on Thursday, February 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, CME Group presently has an average rating of “Moderate Buy” and an average price target of $219.83.

CME Group Trading Down 0.7 %

NASDAQ CME opened at $185.98 on Friday. The stock has a market capitalization of $66.90 billion, a PE ratio of 25.17, a price-to-earnings-growth ratio of 3.59 and a beta of 0.41. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52 week low of $166.54 and a 52 week high of $251.99. The firm has a 50 day moving average of $180.83 and a two-hundred day moving average of $178.86.

CME Group (NASDAQ:CME – Get Rating) last issued its quarterly earnings data on Wednesday, February 8th. The financial services provider reported $1.92 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.02. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. CME Group had a net margin of 53.61% and a return on equity of 10.43%. The company’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.66 EPS. As a group, research analysts expect that CME Group Inc. will post 8.46 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 27th. Stockholders of record on Friday, March 10th will be given a dividend of $1.10 per share. This represents a $4.40 annualized dividend and a dividend yield of 2.37%. The ex-dividend date is Thursday, March 9th. This is an increase from CME Group’s previous quarterly dividend of $1.00. CME Group’s payout ratio is currently 59.54%.

CME Group Profile

(Get Rating)

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.